This inventor holds 2 USPTO granted patents. Top assignee: Dartmouth College. Active years: 2012-2013.
Company Filing History:
Years Active: 2012-2013
Title: David Gondek: Innovator in Regulatory T Cell Proteins
Introduction
David Gondek is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of immunology, particularly in the development of regulatory T cell proteins. With a total of 2 patents, Gondek's work is paving the way for advancements in T cell immunity.
Latest Patents
Gondek's latest patents include innovative discoveries related to regulatory T cell mediator proteins. One of his notable inventions is a protein designated PD-L3, which resembles members of the PD-L1 family and co-stimulates αCD3 proliferation of T cells in vitro. Additionally, he has identified a second TNF-like protein that is upregulated upon αCD3/αGITR stimulation, referred to as T-sTNF. These patents disclose proteins, antibodies, activated T cells, and methods for utilizing these discoveries in therapeutic applications.
Career Highlights
David Gondek is affiliated with Dartmouth College, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to enhance T cell immunity, which is crucial for developing new treatments for various diseases.
Collaborations
Gondek collaborates with esteemed colleagues such as Randolph J Noelle and Li-Fan Lu. Their combined expertise contributes to the advancement of research in the field of immunology.
Conclusion
David Gondek's innovative work in regulatory T cell proteins exemplifies the impact of scientific research on immunology. His contributions are vital for the future of T cell therapies and the understanding of immune regulation.